Tag: life sciences
-
NIH Trials Testing Covid-19 Blood Clot Therapies
National Institutes of Health is starting two clinical trials testing a number of blood thinning treatments for people with blood clots from Covid-19 infections.
-
Antibody Discovery Company Forms, Partners on Covid-19
A new enterprise formed to discover human therapeutic antibodies is partnering with a synthetic biology company to discover Covid-19 antibody treatments.
-
Small Biz Grant Funds Covid-19 Disinfectant Spray
A Florida start-up company is developing a fast-acting disinfectant spray that dries on contact, yet still kills Covid-19 viruses on surfaces.
-
Digital Sedation Company Raises $11.8M in Early Funds
A Belgian company creating virtual reality systems for sedation in surgery and invasive procedures is raising €10 million in its first venture funding round.
-
Biotechs, Pharmas Vow Not to Rush Covid-19 Vaccines
In a joint statement today, CEOs of nine companies promised to follow the highest ethical and scientific standards in development and testing of their Covid-19 vaccines.
-
Small Antibody Shown to Block Covid-19 Infection
Researchers in Sweden found a small-scale antibody grown in an alpaca that in lab tests blocks the SARS-CoV-2 infection mechanism.
-
Brain Signal Synchronization Device in Development
An implantable mental health therapy system is being designed to synchronize signaling rhythms from various regions of the brain.
-
Sanofi, GSK Begin U.S. Covid-19 Vaccine Trial
Global drug makers Sanofi and GlaxoSmithKline are starting a clinical trial testing a vaccine to prevent Covid-19 infections among healthy adults in the U.S.
-
Trial Shows Some ALS Drug Benefit for Patients
Results from a clinical trial show a drug to treat amyotrophic lateral sclerosis slows the functional decline in ALS patients compared to a placebo.
-
Synthetic Antibodies Neutralize Covid-19 Virus Proteins
A company developing synthetic genetic materials and proteins says independent tests show its artificial antibodies neutralize infection mechanisms in Covid-19 viruses.